Abstract:BACKGROUND AND OBJECTIVES: Suprasellar tumors, particularly pituitary adenomas (PAs), commonly present with visual decline, and the endoscopic endonasal transsphenoidal approach (EETA) is the primary management for optic apparatus decompression. Patients presenting with complete preoperative monocular blindness comprise a high-risk subgroup, given concern for complete blindness. This retrospective cohort study evaluates outcomes after EETA for patients with PA presenting with monocular blindness. METHODS: Retrospective analysis of all EETA cases at our institution from June 2012 to August 2023 was performed. Inclusion criteria included adults with confirmed PA and complete monocular blindness, defined as no light perception, and a relative afferent pupillary defect secondary to tumor mass effect. RESULTS: Our cohort includes 15 patients (9 males, 6 females), comprising 2.4% of the overall PA cohort screened. The mean tumor diameter was 3.8 cm, with 6 being giant PAs (>4 cm). The mean duration of preoperative monocular blindness was 568 days. Additional symptoms included contralateral visual field defects (n = 11) and headaches (n = 10). Two patients presented with subacute PA apoplexy. Gross total resection was achieved in 46% of patients, reflecting tumor size and invasiveness. Postoperatively, 2 patients experienced improvement in their effectively blind eye and 2 had improved visual fields of the contralateral eye. Those with improvements were operated within 10 days of presentation, and no patients experienced worsened vision. CONCLUSION: This is the first series of EETA outcomes in patients with higher-risk PA with monocular blindness on presentation. In these extensive lesions, vision remained stable for most without further decline and improvement from monocular blindness was observed in a small subset of patients with no light perception and relative afferent pupillary defect. Timing from vision loss to surgical intervention seemed to be associated with improvement. From a surgical perspective, caution is warranted to protect remaining vision and we conclude that EETA is safe in the management of these patients.

Primary empty sella syndrome associated with visual deterioration salvaged by chiasmapexy: Report of a case and discussion of the literature

Primary sellar melanocytic tumor mimicking hemorrhagic pituitary macroadenoma: Case report and literature review.

Primary choroid plexus papilloma of the sellar region

Resolution of symptomatic secondary empty sella syndrome following lumbar–peritoneal shunt

Endoscope-Assisted Supraorbital Keyhole Approach for the Resection of Benign Tumors of the Sellar Region

A Hypertensive Early-Middle-Aged Man with Loss of Vision: a Rare Case of Primary Empty Sella Syndrome and Central Retinal Vein Occlusion

Optical Coherence Tomography Abnormalities as the Presenting Sign of an Involuted Sellar/Suprasellar Mass

[Opportunities and challenges in the diagnosis and treatment of optic chiasm lesions: a clinical and research perspective]

An unusual presentation of empty sella syndrome in oral and maxillofacial surgery: A case report

Surgical Outcomes and Predictors of Visual Function Alterations after Transcranial Surgery for Large-to-Giant Pituitary Adenomas

[A Case of Papilloedema Caused by Primary Empty Sella Turcica Syndrome].

Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas in Patients Presenting With Monocular Blindness

Clinical analysis of 44 cases of empty sella

Asymptomatic Empty Sella Syndrome: A "New" Hypothalamic Pathology or Paraphysiological Variant

Chronic chiasmal compression and persistent visual field defect without detectable changes in optical coherence tomography of the macular ganglion cell complex

Primary empty sella syndrome presenting as hyponatremia

Brain & chiasmal herniations into sella after medical treatment of prolactinoma

Retrospection of Seldom-Known Causes and Presentations of Partial Empty Sella Syndrome

Empty sella in somatotropic pituitary adenomas; a series of 23 cases

Intrachiasmatic craniopharyngioma: Assessment of visual outcome with optical coherence tomography after complete surgical removal

When atypical becomes urgent: Unleashing the ophthalmologist's role in managing unconventional macroadenomas